REFERENCES
- Proven A, Gabriel SE, Orces C, O’Fallon WM, Hunder GG. Glucocorticoid therapy in giant cell arteritis: duration and adverse outcomes. Arthritis Rheum 2003;49:703–708.
- BSR, and BHPR guidelines for the management of giant cell arteritis. Rheumatology 2010;49:1594–1597
- Sandler NA, Ziccardi V, Ochs M. Differential diagnosis of jaw pain in the elderly. J Am Dent Assoc 1995;126:1263–1272
- Reid IR, Heap SW. Determinants of vertebral mineral density in patients receiving long-term glucocorticoid therapy. Arch Intern Med 1990;150:2545–2548.
- Kanis JA, Johansson H, Oden A, Johnell O, de Laet C, Melton LJ, Tenenhouse A, Reeve J, Silman AJ, Pols HA, Eisman JA, McCloskey EV, Mellstrom DA. A meta-analysis of prior corticosteroid use and fracture risk. J Bone Miner Res 2004;19:893–899.
- Glucocorticoid-induced osteoporosis: guidelines for prevention and treatment. Royal College of Physicians 2002. www.rcplondon.ac.uk/pubs/books/glucocorticoid/. Accessed 21 December 2010.